Shanghai Haoyuan Chemexpress Co., Ltd.

Shanghai Stock Exchange 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD 57.64 M

Shanghai Haoyuan Chemexpress Co., Ltd. Net Cash Used Provided By Financing Activities is USD 57.64 M for the year ending December 31, 2023, a 10.38% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Shanghai Haoyuan Chemexpress Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD 52.21 M, a -67.06% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD 158.53 M, a 1,958.14% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD 7.70 M, a -59.10% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD 18.83 M, a 258.25% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

Shanghai Stock Exchange: 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd.

CEO	Mr. Baofu Zheng
IPO Date	June 8, 2021
Location	China
Headquarters	No. 3 Building, No. 1999
Employees	3,370
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials

Description

Shanghai Haoyuan Chemexpress Co., Ltd. researches and develops pharmaceutical intermediates and small molecule drugs. It manufactures APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

Key trends

Past 5 years